Although the burden of Plasmodium falciparum malaria is gradually declining in many parts
of Africa, it is characterized by spatial and temporal variability that presents new and …

Achieving a malaria-free world presents exciting scientific challenges as well as
overwhelming health, equity, and economic benefits. WHO and countries are setting …

Estimating an epidemic's trajectory is crucial for develo** public health responses to
infectious diseases, but case data used for such estimation are confounded by variable …

Background Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces an antibody response targeting multiple antigens that changes over time. This study …

Infections with Plasmodium falciparum and Plasmodium vivax cause over 600,000 deaths
each year, concentrated in Africa and in young children, but much of the world's population …

A major gap in the Plasmodium vivax elimination toolkit is the identification of individuals
carrying clinically silent and undetectable liver-stage parasites, called hypnozoites. This …

Infection with Plasmodium can elicit antibodies that inhibit parasite survival in the mosquito,
when they are ingested in an infectious blood meal. Here, we determine the transmission …

Background The potential effects of SARS-CoV-2 and Plasmodium falciparum co-infection
on host susceptibility and pathogenesis remain unknown. We aimed to establish the …

Antibodies are unique among biomarkers in their ability to identify persons with protective
immunity to vaccine-preventable diseases and to measure past exposure to diverse …

As many malaria-endemic countries move towards elimination of Plasmodium falciparum,
the most virulent human malaria parasite, effective tools for monitoring malaria epidemiology …